Synmosa Biopharma Corporation at its 2023 special shareholders meeting held on July 13, 2023, approved the appointment of Tu, San-Chien as additional independent director. Resume of the new position holder: Director, Pang Kuei Accounting Firm; Independent Director, Lin BioScience Inc.; Independent Director, SINMAG EQUIPMENT CORPORATION; Independent Director, DAH CHUNG BILLS FINANCE CORP.; and Supervisor, JORJIN TECHNOLOGIES INC. Effective date of the new appointment: July 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.1 TWD | 0.00% | +0.53% | -1.42% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.42% | 446M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director